发明名称 FUSION POLYPEPTIDE CAPABLE OF ACTIVATING RECEPTOR
摘要 <P>PROBLEM TO BE SOLVED: To provide multimeric fusion polypeptides capable of activating a target receptor requiring multimerization to be activated. <P>SOLUTION: The fusion polypeptide comprises (A)<SB POS="POST">x</SB>-M-(A')<SB POS="POST">y</SB>, wherein A and A' are each polypeptides capable of binding the target receptor. The fusion polypeptides form multimeric proteins which activate the target receptor. A and A' may be each an antibody or fragment derived from an antibody specific for the target receptor, such as the same or different ScFv fragments, and/or a ligand or ligand fragment or derivative capable of binding a target protein. M is a multimerizing component, and x and y are independently a number between 1-10. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2012040024(A) 申请公布日期 2012.03.01
申请号 JP20110258048 申请日期 2011.11.25
申请人 REGENERON PHARMACEUTICALS INC 发明人 FANDL JAMES;CHEN GANG;PAPADOPOULOS NICHOLAS;ALDRICH THOMAS H
分类号 C12N15/09;A61K39/395;A61P43/00;C07H21/04;C07K14/515;C07K16/00;C07K16/28;C07K19/00 主分类号 C12N15/09
代理机构 代理人
主权项
地址